A systems approach to designing next generation vaccines: combining α-galactose modified antigens with nanoparticle platforms

Por Phanse, Yashdeep, Carrillo-Conde, Brenda R., Ramer-Tait, Amanda E., Broderick, Scott, Kong, Chang Sun, Rajan, Krishna, Flick, Ramon, Mandell, Robert B., Narasimhan, Balaji, Wannemuehler, Michael J.
Publicado em 2014

Human Monoclonal Antibodies Directed against Toxins A and B Prevent Clostridium difficile-Induced Mortality in Hamsters

Por Babcock, Gregory J., Broering, Teresa J., Hernandez, Hector J., Mandell, Robert B., Donahue, Katherine, Boatright, Naomi, Stack, Anne M., Lowy, Israel, Graziano, Robert, Molrine, Deborah, Ambrosino, Donna M., Thomas, William D.
Publicado em 2006

A replication-incompetent Rift Valley fever vaccine: Chimeric virus-like particles protect mice and rats against lethal challenge

Por Mandell, Robert B., Koukuntla, Ramesh, Mogler, Laura J.K., Carzoli, Andrea K., Freiberg, Alexander N., Holbrook, Michael R., Martin, Brian K., Staplin, William R., Vahanian, Nicholas N., Link, Charles J., Flick, Ramon
Publicado em 2010

Rho GTPases Modulate Entry of Ebola Virus and Vesicular Stomatitis Virus Pseudotyped Vectors

Por Quinn, Kathrina, Brindley, Melinda A., Weller, Melodie L., Kaludov, Nikola, Kondratowicz, Andrew, Hunt, Catherine L., Sinn, Patrick L., McCray, Paul B., Stein, Colleen S., Davidson, Beverly L., Flick, Ramon, Mandell, Robert, Staplin, William, Maury, Wendy, Chiorini, John A.
Publicado em 2009